We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$384M
AUM Growth
-$11.9M
(-3%)
Cap. Flow
-$26.9M
Cap. Flow
% of AUM
-7%
Top 10 Holdings %
Top 10 Hldgs %
45.73%
Holding
98
New
2
Increased
52
Reduced
26
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$5.01M |
| 2 |
XYZ
Block Inc
XYZ
|
+$2.41M |
| 3 |
MZOR
Mazor Robotics Ltd.
MZOR
|
+$1.53M |
| 4 |
Boston Omaha
BOC
|
+$967K |
| 5 |
Alibaba
BABA
|
+$890K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$6.99M |
| 2 |
Meta Platforms (Facebook)
META
|
+$6.96M |
| 3 |
BAC.WS.A
Bank Of America Corporation Ws A
BAC.WS.A
|
+$6.45M |
| 4 |
JPM.WS
JPMorgan Chase
JPM.WS
|
+$4.54M |
| 5 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$3.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.96% |
| 2 | Financials | 13.71% |
| 3 | Technology | 8.68% |
| 4 | Communication Services | 8.47% |
| 5 | Energy | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$477B
| $33.4M | 8.7% |
190,753
-15,714
| -8% | -$2.69M |
|
2
Intuitive Surgical
ISRG
$121B
| $32M | 8.34% |
232,635
-15,993
| -6% | -$2.23M |
|
3
Apple
AAPL
$4.89T
| $21.4M | 5.57% |
510,036
-25,320
| -5% | -$1.09M |
|
|
ABMD
4
DELISTED
Abiomed Inc
ABMD
| $21.2M | 5.53% |
72,899
+3,105
| +4% | +$787K |
|
5
Idexx Laboratories
IDXX
$42.9B
| $12.8M | 3.33% |
66,771
-8,641
| -11% | -$1.59M |
|
6
Alphabet (Google) Class A
GOOGL
$3.91T
| $12.2M | 3.18% |
235,660
+3,700
| +2% | +$205K |
|
|
7
Meta Platforms (Facebook)
META
$1.51T
| $11.4M | 2.97% |
71,420
-38,765
| -35% | -$6.96M |
|
8
Illumina
ILMN
$29.4B
| $11.2M | 2.91% |
48,638
+2,090
| +4% | +$479K |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $10M | 2.61% |
112,276
-18,426
| -14% | -$1.77M |
|
10
JPMorgan Chase
JPM
$939B
| $9.89M | 2.58% |
89,943
-2,935
| -3% | -$332K |
|
|
BAC.WS.A
11
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $9.42M | 2.45% |
518,242
-329,985
| -39% | -$6.45M |
|
12
Diamondback Energy
FANG
$57.6B
| $8.86M | 2.31% |
70,062
+6,720
| +11% | +$847K |
|
|
13
Alibaba
BABA
$269B
| $8.79M | 2.29% |
47,899
+4,725
| +11% | +$890K |
|
14
Bristol-Myers Squibb
BMY
$127B
| $7.4M | 1.93% |
116,965
+305
| +0.3% | +$19.6K |
|
15
VF Corp
VFC
$6.68B
| $7.04M | 1.83% |
100,824
-191
| -0.2% | -$13.8K |
|
|
JPM.WS
16
DELISTED
JPMorgan Chase
JPM.WS
| $6.95M | 1.81% |
99,860
-62,192
| -38% | -$4.54M |
|
17
SLB Ltd
SLB
$77.8B
| $6.51M | 1.7% |
99,742
+5,225
| +6% | +$365K |
|
|
XYZ
18
Block Inc
XYZ
$45.9B
| $6.42M | 1.67% |
130,475
+52,550
| +67% | +$2.41M |
|
19
Lockheed Martin
LMT
$134B
| $6.08M | 1.58% |
17,883
-43
| -0.2% | -$14.6K |
|
20
AbbVie
ABBV
$458B
| $5.99M | 1.56% |
63,251
-30
| -0% | -$3.3K |
|
21
Chevron
CVX
$388B
| $5.7M | 1.49% |
49,530
-25
| -0.1% | -$2.99K |
|
|
MZOR
22
DELISTED
Mazor Robotics Ltd.
MZOR
| $5.68M | 1.48% |
92,570
+24,470
| +36% | +$1.53M |
|
23
Regeneron Pharmaceuticals
REGN
$68.8B
| $5.66M | 1.47% |
16,434
+282
| +2% | +$98.1K |
|
24
Vertex Pharmaceuticals
VRTX
$121B
| $5.54M | 1.44% |
33,975
+4,720
| +16% | +$771K |
|
25
Intel
INTC
$466B
| $5.49M | 1.43% |
104,814
-542
| -0.5% | -$25.8K |
|
Similar funds
LA
UBV
SG
RTM
TCMX
QCMNJ
TIS
MO
Biondo Investment Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Biondo Investment Advisors held 98 positions worth $384M, down 3% from $396M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Biondo Investment Advisors withdrew a net $26.9M in Q1 2018, closing 10 positions and reducing 26 holdings. Its most notable exit was Pacira BioSciences, an estimated $6.99M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Financials and Technology.
Against the trend, Biondo Investment Advisors opened a new position in Boston Omaha worth $919K.
- Biondo Investment Advisors's largest Q1 2018 buy was Boston Omaha: 42,025 shares worth $919K.
- Biondo Investment Advisors added most to Procter & Gamble in Q1 2018, an estimated $5.01M increase.
- Biondo Investment Advisors's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $6.96M.
- Biondo Investment Advisors fully exited Pacira BioSciences in Q1 2018, selling an estimated $6.99M.
- Biondo Investment Advisors's ten largest holdings make up 46% of its $384M portfolio in Q1 2018.
- Biondo Investment Advisors opened 2 new positions and closed 10 in Q1 2018.
- Biondo Investment Advisors's portfolio value fell 3% quarter-over-quarter to $384M.
Based on Biondo Investment Advisors's 13F filing for Q1 2018, filed 2 May 2018.